GenevaDRC’s Ebola outbreak has killed nearly 1,000 people.
New data suggest Merck’s Ervebo, licensed only against the Zaire ebolavirus, may also block the Bundibugyo species now spreading.
WHO’s vaccine expert panel meets in October to decide whether to test Ervebo in the outbreak zone.
Sources: STAT